Drug Cryptomarkets in the 2020s:Policy, Enforcement, Harm, and Resilience
Martin Horton-Eddison, Patrick Shortis, Judith A. Aldridge, Fernando Caudevilla · CrimRxiv · 2021
This GDPO Policy Brief is intended to inform policy-makers, practitioners, and other actors of the latest developments – and likely future direction – of Drug Cryptomarkets (DCM). It draws together several complementary active research strands to provide a timely trend analysis of the current and future state of the DCM landscape, clarifies the impact of a decade of counter-DCM policy and enforcement strategy on market development, and proposes suggestions for future enforcement strategies and wider policy guidance for the coming decade.